venBio

Biotech venture capital still booming as venBio raises another $550M
BioPharma Dive
Thu, 06/3/21 - 10:58 pm
venBio
venture capital
Barely two months after unveiling a new breed of radiopharmaceuticals, RayzeBio brings total haul to $150M
Endpoints
Tue, 12/8/20 - 10:52 am
RayzeBio
radiopharmaceuticals
Versant
venBio
Novartis bet $6B on the idea — now Versant, venBio have $45M to birth a platform play for radiopharmaceuticals
Endpoints
Wed, 10/14/20 - 10:51 am
Versant Ventures
PSMA-617
radiopharmaceuticals
prostate cancer
Novartis
Rayze Bio
venBio
venBio closes third fund for biopharma startup investment, valued at $394M
MedCity News
Mon, 04/6/20 - 10:28 am
venBio
NASH
startups